Medtronic plc (MDT) Q3 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medtronic Plc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.696 and we look forward to bringing this unique catheter to the U.S. 00:00:04.696 -- 00:00:10.442 Beyond Cas, we're also making material progress with Simplicity Spiral for hypertension 00:00:10.442 -- 00:00:13.966 and AltaViva for urge urinary incontinence. 00:00:13.966 -- 00:00:19.251 Simplicity delivers a one-time, durable, minimally invasive treatment for hypertension 00:00:19.251 -- 00:00:21.914 and represents one of our largest growth drivers. 00:00:21.914 -- 00:00:27.219 Now, this is going to be a contributor for years to come, given the 18 million 00:00:27.219 -- 00:00:30.473 U.S. patients with uncontrolled hypertension. 00:00:30.473 -- 00:00:35.501 We're seeing strong patient outcomes in the field, and the RDN value proposition, it 00:00:35.501 -- 00:00:39.126 resonates with both physicians and patients. 00:00:39.126 -- 00:00:44.615 Now we've got strong and growing clinical data, a broad label, and expanding 00:00:44.615 -- 00:00:48.561 reimbursement all in hand. Look, we've built the foundation. 00:00:48.561 -- 00:00:53.689 Now we're focused on growing this new segment and transforming the hypertension treatment 00:00:53.689 -- 00:00:58.017 paradigm. We've recently activated our direct-to-consumer 00:00:58.017 -- 00:01:03.366 Go Beyond campaign in key markets around the U.S., which is resulting in a 50 00:01:03.366 -- 00:01:06.792 times increase in website visits versus the prior quarter. 00:01:06.792 -- 00:01:10.294 So a lot of interest coming in from patients. 00:01:10.538 -- 00:01:15.306 Building a new market, it does take time. That is something Medtronic knows how to do 00:01:15.306 -- 00:01:20.595 exceptionally well. And in parallel to building out this new market, we're innovating 00:01:20.595 -- 00:01:26.066 for the l...